Phibro Animal Health Corporation (PAHC)

Market Cap	878.52M
Revenue (ttm)	1.05B
Net Income (ttm)	17.41M
Shares Out	40.50M
EPS (ttm)	0.43
PE Ratio	50.47
Forward PE	12.66
Dividend	$0.48 (2.21%)
Ex-Dividend Date	Nov 27, 2024

Volume	588,160
Open	21.47
Previous Close	21.81
Day's Range	21.41 - 22.40
52-Week Range	10.04 - 25.98
Beta	0.50
Analysts	Sell
Price Target	20.50 (-5.49%)
Earnings Date	Feb 5, 2025

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Apr 11, 2014
• Employees: 1,940
• Stock Exchange: NASDAQ
• Ticker Symbol: PAHC
• Website: https://www.pahc.com

Financial Performance

In 2024, Phibro Animal Health's revenue was $1.02 billion, an increase of 4.07% compared to the previous year's $977.89 million. Earnings were $2.42 million, a decrease of -92.59%.

Analyst Forecast

According to 4 analysts, the average rating for PAHC stock is "Sell." The 12-month stock price forecast is $20.5, which is a decrease of -5.49% from the latest price.

Price Target

$20.5

(-5.49% downside)

Analyst Consensus: Sell